SYSTEMS FOR CAPILLARY-BASED SAMPLE HANDLING

Information

  • Research Project
  • 6155141
  • ApplicationId
    6155141
  • Core Project Number
    R24HG002210
  • Full Project Number
    1R24HG002210-01
  • Serial Number
    2210
  • FOA Number
    PAR-99-047
  • Sub Project Id
  • Project Start Date
    6/1/2000 - 24 years ago
  • Project End Date
    4/30/2002 - 22 years ago
  • Program Officer Name
    SCHLOSS, JEFFERY
  • Budget Start Date
    6/1/2000 - 24 years ago
  • Budget End Date
    4/30/2001 - 23 years ago
  • Fiscal Year
    2000
  • Support Year
    1
  • Suffix
  • Award Notice Date
    8/7/2000 - 23 years ago

SYSTEMS FOR CAPILLARY-BASED SAMPLE HANDLING

The goal is to develop and implement a novel technology for high throughput, capillary based sample handling, purification, and thermocycling to achieve a ten-fold cost reduction relative to "1/4x" ABI sequencing reactions, and a production capacity of 50,000 samples per day. Purification of E. coli lysates and sequencing reactions will be accomplished by micro-volume, modular flow-through dialysis devices using commercially available ultrafiltration membranes for which "proof of principle" has already been demonstrated. The membrane capillaries will be configured in molded cassettes such that 96 or more samples can be processed in parallel, using standard micro-well plates as sample sources. During Year-1 we will develop and test the cassettes and the liquid handling stations. During Year-2, we will produce quantities of cassettes and will place systems for evaluation at GTC, the Baylor College of Medicine, and the DOE Joint Genome Institute. During Year-3 we will implement a small-format, fully automated sample handling system at the GTC Sequencing Center and will place plasmid purification modules at the other two centers. We will also collaborate with Molecular Dynamics to develop a capillary cassette loader for their new-generation microchannel sequencer. This will allow seamless integration of the entire pipeline from E. coli clones to gel separation with sub-microliter sample volumes and a minimum of plate transfers and plastic disposables.

IC Name
NATIONAL HUMAN GENOME RESEARCH INSTITUTE
  • Activity
    R24
  • Administering IC
    HG
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    746682
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    172
  • Ed Inst. Type
  • Funding ICs
    NHGRI:746682\
  • Funding Mechanism
  • Study Section
    ZHG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    OSCIENT PHARMACEUTICALS CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    WALTHAM
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    024538443
  • Organization District
    UNITED STATES